pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    cetrelimab
    cetrelimab
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$JNJ JOHNSON & JOHNSON
  • Marketed
    cetuximab
    Erbitux (cetuximab)
    Head And Neck Squamous Cell Carcinoma (HNSC) Eli Lilly Interamerica Inc
  • Phase 3
    cetuximab sarotalocan
    cetuximab sarotalocan
    Recurrent Head And Neck Squamous Cell Carcinoma Rakuten Medical Inc
← prev
page 43 of 62
next →
Pain89
Neurology1
Phase 2
cevostamab
cevostamab
Refractory Multiple Myeloma
Genentech Inc
  • Marketed
    chlorambucil
    Leukeran (chlorambucil [INN])
    Chronic Lymphocytic Leukemia (CLL) GlaxoSmithKline LLC
  • Preclinical
    chrysoeriol
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Flavocure Biotech Inc
  • Phase 2
    ciforadenant
    ciforadenant
    Renal Cell Carcinoma$CRVS Corvus Pharmaceuticals, Inc.
  • Marketed
    ciltacabtagene autoleucel
    Carvykti (ciltacabtagene autoleucel)
    Refractory Multiple Myeloma Janssen Biotech Inc
  • Phase 2
    ciltistotug
    ciltistotug
    Metastatic Melanoma Eucure (Beijing) Biopharma Co Ltd
  • Marketed
    cimetidine
    Cimetidine
    Acid Indigestion (Heartburn/Pyrosis) L. Perrigo Company
  • Marketed
    cimetidine hydrochloride
    Cimetidine Hydrochloride
    Duodenal Ulcer Chartwell Pharmaceuticals LLC
  • Phase 3
    cintredekin besudotox
    cintredekin besudotox
    Glioblastoma Multiforme (GBM) Precision Neuromed Inc
  • Preclinical
    clofarabine
    Clofarabine Winthrop (clofarabine)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) BoYen Therapeutics Inc
  • Marketed
    cobimetinib fumarate
    Cotellic (cobimetinib fumarate)
    Erdheim-Chester Disease (Erdheim–Chester Syndrome/ Polyos… Genentech Inc
  • Marketed
    copanlisib hydrochloride
    Aliqopa (copanlisib hydrochloride)
    Follicular Lymphoma Bayer HealthCare Pharmaceuticals Inc
  • Phase 3
    crenolanib besylate
    crenolanib besylate
    Refractory Acute Myeloid Leukemia Arog Pharmaceuticals Inc
  • Phase 3
    cretostimogene grenadenorepvec
    cretostimogene grenadenorepvec
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$CGON CG Oncology, Inc.
  • Marketed
    crizotinib
    Xalkori (crizotinib)
    Anaplastic Large Cell Lymphoma (ALCL)$PFE PFIZER INC
  • Phase 2
    cusatuzumab
    cusatuzumab [INN]
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) OncoVerity Inc
  • Marketed
    cytarabine
    Cytarabine
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Meitheal Pharmaceuticals Inc
  • Phase 2
    dabogratinib
    dabogratinib [INN]
    Achondroplasia$TYRA Tyra Biosciences, Inc.
  • Marketed
    dabrafenib mesylate + trametinib dimethyl sulfoxide
    Tafinlar + Mekinist (dabrafenib mesylate + trametinib dimethyl sulfoxide)
    Anaplastic Thyroid Cancer$NVS NOVARTIS AG
  • Marketed
    dacarbazine
    Dacarbazine
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Meitheal Pharmaceuticals Inc
  • Marketed
    dacomitinib
    Vizimpro (dacomitinib)
    Non-Small Cell Lung Cancer$PFE PFIZER INC
  • Marketed
    dactinomycin
    Dactinomycin
    Choriocarcinoma (Gestational Trophoblastic Neoplasia) Hisun Pharmaceutical USA Inc
  • pre_registration
    daratumumab
    Darzalex (daratumumab)
    Multiple Myeloma (Kahler Disease)$JNJ JOHNSON & JOHNSON
  • Phase 2
    daretabart
    daretabart [INN]
    Neuroblastoma Essential Holdings Ltd
  • Phase 2
    darinaparsin
    darinaparsin
    Peripheral T-Cell Lymphomas (PTCL) Solasia Pharma KK
  • Phase 1
    darlifarnib
    darlifarnib [INN]
    Head And Neck Squamous Cell Carcinoma (HNSC)$KURA Kura Oncology, Inc.
  • Marketed
    darolutamide
    Nubeqa (darolutamide)
    Castration-Resistant Prostate Cancer (CRPC) Bayer HealthCare Pharmaceuticals Inc